Europe — EMA
Meropur (Menotrophin)
GNH USA supplies Meropur (Menotrophin), a gonadotropin preparation for ovulation induction and controlled ovarian hyperstimulation.
Request sourcing
What is Menotrophin?
Menotrophin, the active ingredient in Meropur, is a gonadotropin (FSH and LH preparation) presented as a sterile solution for intramuscular, subcutaneous use. It treats infertility in women by stimulating ovarian follicular development and ovulation. GNH USA supplies Meropur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Menotrophin used for?
Meropur is a gonadotropin preparation used in reproductive medicine to support follicular growth and ovulation. - Ovulation induction: promotes the development of a dominant follicle to trigger ovulation in anovulatory women. - Controlled ovarian hyperstimulation: enhances multiple follicle development for assisted reproductive technologies such as IVF. - Infertility treatment: improves the chances of conception in couples experiencing female factor infertility.
What are the side effects of Menotrophin?
Adverse reactions may occur with Menotrophin therapy and are categorized by frequency.
Common Side Effects: - Injection site pain or erythema - Abdominal discomfort or bloating - Headache - Nausea or mild vomiting - Breast tenderness - Mild ovarian hyperstimulation
Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (OHSS) - Multiple pregnancy - Allergic reactions including rash or anaphylaxis - Thromboembolic events - Pulmonary edema - Severe abdominal pain with ascites
What precautions apply to Menotrophin?
Before initiating Menotrophin therapy, clinicians should consider several safety measures. - Baseline assessment: evaluate ovarian reserve and baseline estradiol levels. - Monitoring: perform regular ultrasound and hormone monitoring to detect excessive response. - Hypersensitivity: avoid in patients with known allergy to gonadotropins or excipients. - Cysts or tumors: contraindicated in the presence of ovarian cysts or estrogen‑dependent neoplasms. - Thyroid disease: use caution in uncontrolled thyroid disorders. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Menotrophin interact with?
Menotrophin may interact with other agents that influence ovarian function or coagulation.
Major Interactions (Avoid): - GnRH agonists: can cause excessive ovarian stimulation when combined. - hCG: increases risk of severe ovarian hyperstimulation syndrome. - Estrogen‑containing contraceptives: may blunt the intended gonadotropin effect.
Moderate Interactions (Monitor Closely): - Anticoagulants: heightened thrombosis risk if severe OHSS develops. - Corticosteroids: may alter follicular response and hormone levels.



